Bloomer J C, Clarke S E, Chenery R J
Department of Drug Metabolism and Pharmacokinetics, SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, UK.
Drug Metab Dispos. 1997 Jul;25(7):840-4.
The in vitro metabolism of ropinirole was investigated with the aim of identifying the cytochrome P450 enzymes responsible for its biotransformation. The pathways of metabolism after incubation of ropinirole with human liver microsomes were N-despropylation and hydroxylation. Enzyme kinetics demonstrated the involvement of at least two enzymes contributing to each pathway. A high affinity component with a K(M) of 5-87 microM and a low affinity component with a K(M) of approximately two orders of magnitude greater were evident. The high affinity component could be abolished by pre-incubation of the microsomes with furafylline. Additionally, incubation of ropinirole with microsomes derived from CYP1A2 transfected cells readily produced the N-despropyl and hydroxy metabolites. Some inhibition of ropinirole metabolism was also observed with ketoconazole, indicating a minor contribution by CYP3A. Multivariate correlation data were consistent with the involvement of the cytochrome P450 enzymes 1A2 and 3A in the metabolism of ropinirole. Thus, it could be concluded that the major P450 enzyme responsible for ropinirole metabolism at lower (clinically relevant) concentrations is CYP1A2 with a contribution from CYP3A, particularly at higher concentrations.
为了确定参与罗匹尼罗生物转化的细胞色素P450酶,对其体外代谢进行了研究。罗匹尼罗与人肝微粒体孵育后的代谢途径为N-去丙基化和羟基化。酶动力学表明,每条途径至少涉及两种酶。明显存在一个K(M)为5 - 87 microM的高亲和力组分和一个K(M)大约高两个数量级的低亲和力组分。通过用呋拉茶碱预孵育微粒体,可以消除高亲和力组分。此外,罗匹尼罗与源自CYP1A2转染细胞的微粒体孵育很容易产生N-去丙基和羟基代谢物。酮康唑也观察到对罗匹尼罗代谢有一些抑制作用,表明CYP3A有较小贡献。多变量相关数据与细胞色素P450酶1A2和3A参与罗匹尼罗代谢一致。因此,可以得出结论,在较低(临床相关)浓度下负责罗匹尼罗代谢的主要P450酶是CYP1A2,CYP3A也有贡献,特别是在较高浓度时。